Selpercatinib

ATC L01EX22 · 9 markets · 41 records

Selpercatinib 9 markets · 41 records Forms

AU 12 records · 7 strengths

  • 80 mgcapsuleRETEVMORETEVMO selpercatinib 80 mg immediate release capsules also in US·GB·CA +3 unknown
  • 40 mgcapsuleRETEVMORETEVMO selpercatinib 80 mg immediate release capsules also in US·GB·CA +3 unknown
  • 80 mgtabletRETEVMORETEVMO selpercatinib 40 mg film-coated tablets blister pack also in US·GB·CA +2 unknown
  • 40 mgtabletRETEVMORETEVMO selpercatinib 40 mg film-coated tablets blister pack also in US·GB·CA +2 unknown
  • 160 mgtabletRETEVMO selpercatinib 40 mg film-coated tablets blister pack also in US unknown
  • 120 mgtabletRETEVMO selpercatinib 40 mg film-coated tablets blister pack also in US unknown

Records without a stated strength · 1 RETEVMO

US 6 records · 6 strengths

GB 4 records · 4 strengths

CA 4 records · 4 strengths

SG 4 records · 4 strengths

ES 4 records · 4 strengths

TW 2 records · 2 strengths

HK 2 records · 1 strengths

    Records without a stated strength · 1 Retsevmo 40mg capsules

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      Records without a stated strength · 1 Retsevmo 40mg capsules

      Side-by-side table

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.